Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

NCT00173316CI-TRIAL-00000148unknownClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Oral Cancer	Malignant Lip and Oral Cavity Neoplasm	CURATED_BROADER	0.80

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years
Maximum age: 85 Years

Show eligibility criteria text

Inclusion Criteria:

* oral cancer and oral precancer specimens

Exclusion Criteria:

* other diseases

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Aug 1, 2004
Primary completion: —
Completion: Jun 1, 2005
First posted: Sep 15, 2005
Last update posted: Sep 15, 2005
Enrollment: 80
Lead sponsor: National Taiwan University Hospital OTHER
Keywords: vascular endothelial growth factor-C, VEGF-CR, lymphangiogenesis, host inflammatory responses, oral carcinogenesis, oral cancers, oral premalignant lesions

Data updated 22 days agoSource updated Sep 15, 2005source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
Taiwan	1	1

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.